Wnt/beta-catenin-IN-6 Preis auf Anfrage

Catalog Number: MCE-HY-172920
Article Name: Wnt/beta-catenin-IN-6 Preis auf Anfrage
Biozol Catalog Number: MCE-HY-172920
Supplier Catalog Number: HY-172920
Alternative Catalog Number: MCE-HY-172920-10MG,MCE-HY-172920-50MG,MCE-HY-172920-100MG,MCE-HY-172920-25MG,MCE-HY-172920-5MG
Manufacturer: MedchemExpress
Category: Biochemikalien
Wnt/beta-catenin-IN-6 is an orally active Wnt/beta-catenin pathway inhibitor. Wnt/beta-catenin-IN-6 blocks the AKT/GSK-3beta/beta-catenin signaling pathway, leading to reduced expression of Wnt target genes (c-Myc, c-Jun). Wnt/beta-catenin-IN-6 reduces COX2 expression and IL-8 levels, highlighting its dual anti-inflammatory and antitumor effects. Wnt/beta-catenin-IN-6 serves as a tool for non-small cell lung cancer (NSCLC) research[1].
Molecular Weight: 426.47
Purity: 98.34
Formula: C25H22N4O3
Target: Akt,Apoptosis,c-Myc,COX,EGFR,ERK,GSK-3,Interleukin Related,JNK,Wnt,beta-catenin
Application Notes: MCE Product type: Reference compound